Page last updated: 2024-11-12

nosiheptide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

nosiheptide: from Streptomyces actuosus; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID16129637
CHEBI ID29657
MeSH IDM0062431

Synonyms (7)

Synonym
56377-79-8
C12053 ,
nosiheptide
nosiheptide (usan/inn)
D02392 ,
CHEBI:29657
Q27110210

Research Excerpts

Overview

Nosiheptide is a bicyclic thiopeptide featuring an indole-containing side ring, which is biologically important in maintaining its potent antibacterial activity. It is a ribosomally synthesized and post-translationally modified thiopesptide natural product that possesses antibacterial, anticancer, and immunosuppressive properties.

ExcerptReferenceRelevance
"Nosiheptide is a bicyclic thiopeptide featuring an indole-containing side ring, which is biologically important in maintaining its potent antibacterial activity. "( Mutasynthesis Generates Antibacterial Benzothiophenic-Containing Nosiheptide Analogues.
Chen, D; Guo, H; Liu, W; Mu, N; Wang, S; Wang, W; Yin, Y; Zhang, E, 2022
)
2.4
"Nosiheptide (NOS) is a highly modified thiopeptide antibiotic that displays formidable in vitro activity against a variety of Gram-positive bacteria. "( Rerouting the Pathway for the Biosynthesis of the Side Ring System of Nosiheptide: The Roles of NosI, NosJ, and NosK.
Badding, ED; Boal, AK; Booker, SJ; Gadsby, LK; Grove, TL; LaMattina, JW, 2017
)
2.13
"Nosiheptide is a prototypal thiopeptide antibiotic, containing an indole side ring in addition to its thiopeptide-characteristic macrocylic scaffold. "( Biosynthesis of the nosiheptide indole side ring centers on a cryptic carrier protein NosJ.
Deng, Z; Ding, W; Ji, W; Liu, WQ; Ma, X; Mo, T; Tang, B; Wu, R; Wu, Y; Xu, P; Yu, Y; Zhang, Q; Zhang, W; Zhao, J, 2017
)
2.22
"Nosiheptide is a ribosomally synthesized and post-translationally modified thiopeptide natural product that possesses antibacterial, anticancer, and immunosuppressive properties. "( Capturing Intermediates in the Reaction Catalyzed by NosN, a Class C Radical S-Adenosylmethionine Methylase Involved in the Biosynthesis of the Nosiheptide Side-Ring System.
Booker, SJ; LaMattina, JW; Marshall, SL; Wang, B, 2019
)
2.16
"Nosiheptide is an archetypal thiopeptide antibiotic, possessing a characteristic macrocyclic core that contains a 6-membered heterocycle central to multiple azol(in)es and dehydroamino acids. "( Opportunities and challenges from current investigations into the biosynthetic logic of nosiheptide-represented thiopeptide antibiotics.
Liu, W; Wang, S; Zhou, S, 2013
)
2.05
"Nosiheptide is a parent compound of thiopeptide family that exhibit potent activities against various bacterial pathogens. "( Structure-based Mechanistic Insights into Terminal Amide Synthase in Nosiheptide-Represented Thiopeptides Biosynthesis.
Cao, C; Ding, J; Guo, H; Han, L; Lan, W; Liu, S; Liu, W; Rong, N; Wang, C; Wang, R; Yao, P; Yu, Y; Zhang, T; Zhang, Y, 2015
)
2.09
"Nosiheptide is a member of the thiopeptide family of antibiotics which demonstrates potent activities against various bacterial pathogens. "( Crystallographic analysis of NosA, which catalyzes terminal amide formation in the biosynthesis of nosiheptide.
Cao, C; Ding, J; Lan, W; Liu, S; Liu, W; Wang, C; Wang, Y; Yao, P; Yu, Y; Zhang, Y, 2015
)
2.08
"Nosiheptide is a lipophilic peptide of significant anti-hepatitis B virus (anti-HBV) activity in cell culture, but has poor distribution to liver in vivo. "( Recombinant high-density lipoprotein complex as a targeting system of nosiheptide to liver cells.
Cai, Q; Feng, M; Guo, X; Huang, H; Shi, X; Zhou, P, 2008
)
2.02

Bioavailability

ExcerptReferenceRelevance
" Furthermore, the in vivo production of variants can be employed to interrogate thiopeptide structure-activity relationships and may be useful to address the bioavailability issues plaguing these otherwise promising lead molecules."( In vivo production of thiopeptide variants.
Kelly, WL; Zhang, F, 2012
)
0.38
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
polyolA compound that contains two or more hydroxy groups.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (66)

TimeframeStudies, This Drug (%)All Drugs %
pre-19909 (13.64)18.7374
1990's3 (4.55)18.2507
2000's11 (16.67)29.6817
2010's37 (56.06)24.3611
2020's6 (9.09)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 32.94

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index32.94 (24.57)
Research Supply Index4.23 (2.92)
Research Growth Index5.17 (4.65)
Search Engine Demand Index39.41 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (32.94)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (1.49%)5.53%
Reviews4 (5.97%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other62 (92.54%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]